期刊文献+

氟尿嘧啶缓释剂在腹腔镜局部进展期结直肠癌手术中应用的临床研究 被引量:14

Clinical research on the effects of intraoperative intraperitoneal chemotherapy with sustained-release 5-fluorouracil for laparoscopic treatment of locally advanced colorectal cancer
下载PDF
导出
摘要 目的评价腹腔镜手术中局部植入氟尿嘧啶缓释剂对局部进展期结直肠癌腹腔镜手术的治疗作用。方法对60例局部进展期(T4N0M0及Ⅲ期)结直肠癌患者行腹腔镜结直肠癌根治性手术,分为治疗组(n=29):术中局部植入氟尿嘧啶缓释剂600 mg;对照组(n=31):术中以氟尿嘧啶注射液1 000 mg冲洗腹腔。两组患者术后化疗方案相同。回顾性分析两组患者的局部复发和远处转移例数以及3年生存率。结果治疗组的1年、3年局部复发率和远处转移率以及1年、3年生存率均优于对照组(P<0.05)。结论术中局部植入氟尿嘧啶缓释剂可降低腹腔镜局部进展期结直肠癌术后局部复发率,并可提高3年生存率。 Objective To assess the effects of intraoperative intraperitoneal chemotherapy with sustained release 5-fluorouracil for inplantation for the laparoscopic treatment of locally advanced colorectal cancer. Methods A total of 60 patients with locally advanced primary colorectal cancer (T4N0M0 and stage Ⅲ) undergoing lapa- roscopic radical resection were divided into treatment group (n = 29, intraoperative intraperitoneal chemotherapy with 600 mg sustained release 5-fluorouracil) and control group( n = 31, intraoperative intraperitoneal flushing with 1 000 mg 5-fluorouracil injection). Both groups received the same postoperative chemotherapy regime. The 3-year survival rate, local recurrence rate and distant metastasis rate were retrospectively analysed. Results The 3-year survival rate and local recurrence rate were more favorable in treatment group than those in control group ( P 〈 0. 05) ,while there was no significant difference in distant metastasis rate between these two groups (P 〉 0. 05 ). Conclusions Intraoperative intraperitoneal chemotherapy with sustained release 5-fluorouracil may decrease post-operative local recurrence rate and increase 3-year survival rate of locally advanced colorectal cancer.
出处 《中国肿瘤外科杂志》 CAS 2015年第4期220-222,共3页 Chinese Journal of Surgical Oncology
关键词 氟尿嘧啶缓释剂 局部进展期结直肠癌 腹腔镜手术 局部复发 远处转移 sustained-release 5-fluorouracil locally advanced colon cancer laparoscopic surgery local recurrence distant metastasis
  • 相关文献

参考文献14

  • 1Sieqel R,Ma J,Zou Z,et al. Cancer Statistics,2014[ J]. CA Canc- er J Clin,2014,64( 1 ) :9-29.
  • 2Sethna KS,Sugarbaker PH. New prospects for the control of peritoneal surface dissemination of gastric cancer using perioperative intraper- itoneal chemotherapy[ J]. Cancer Therapy,20lM ,2(A) :79-84.
  • 3Kim MS, Choi C, Yoo S, et al. Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma [ J ]. Jpn J Clin Onco1,2008,38(10) :695-700.
  • 4Glehen O, Gilly FN, Sugarbaker PH. New perspectives in the management of colorectal cancer: what about peritoneal carcinoma- tosis[J]. Scand J Surg, 2003, 92(2) : 178-179.
  • 5Glehen O, Mithieux F, Osinsky D, et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study [ J ]. J Clin Oncol, 2003, 21 (5) :799-806.
  • 6Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer:a multi-institutional study [J]. J Clin Oncol 2004, 22 (16) : 3284-3292.
  • 7马骖,单宏杰,包召玉,梅天明,倪进斌.进展期胃癌术中植入5-氟尿嘧啶缓释剂的临床观察[J].中国肿瘤外科杂志,2013,5(1):58-59. 被引量:6
  • 8Yoshikawa R, Kusunoki M, Yanagi I-I, et al. Dual antitumor effects of 5-flunrouracil on the cell cycle in colorectaI carcinoma ceils: a novel target mechanism concept for pharmacerokinetic modulating chemotherapy[ J]. Cancer Res ,2001,61 ( 3 ) : 1029-1037.
  • 9Di Paolo A, Danesi R, Falcone A, et al. Relationship between 5- fluorouracil disposition, toxicity and dihydropyrimidine dehydro- genase activity in cancer patients [ J ]. Ann Oncol, 2001, 12 ( 9 ) : 1301-1306.
  • 10Van Kuilenburg AB, Haasjes J, Richel DJ, et al. Clinical impli- cations of dihydropyrimidine dehydrogenase ( DPD ) deficiency in patients with severe 5-fluorouracil associated toxicity : identif ica- tion of new mutations in the DPD gene [ J ]. Clin Cancer Res, 2000, 6(12) : 4705-4712.

二级参考文献5

共引文献5

同被引文献116

  • 1刘爱国,梅蔚德,许健健,喻平.缓释植入化疗药物的临床研究进展[J].癌症进展,2004,2(4):270-276. 被引量:81
  • 2杨刚.结直肠癌TNM分期第六版介绍[J].中华胃肠外科杂志,2004,7(6):482-482. 被引量:23
  • 3郑民华,主编.普通外科腹腔镜手术操作规范与指南[M].北京:人民卫生出版社,2009:25.
  • 4Petrelli F, Coinu A, Ghilardi M, et al. Efficacy of oxaliplatin-based chemotherapy + bevacizumab as first-line treatment for advanced colorectal cancer: a systematic review and pooled analysis of pub-lishedtrials[J].AmJClinOncol,2015,38(2):227-233.
  • 5Neumann H, Nigel A,Buda A. Advanced endoscopic imaging to im- prove adenoma detection [ J ]. World J Gastrointest Endosc, 2015,7 (3) :224 -229.
  • 6Chen W,Zheng R, Baade PD, et al. Cancer statistics in China,2015 [J]. CA Cancer J Clin,2016,66(2) : 115-132.
  • 7De PA, Innocente R, Buonadonna A, et al. Neoadjuvant therapy of rectal cancer new treatment perspectives [J]. Tumori, 2004,90(4) : 373-378.
  • 8Sieqel R,Ma J,Miller K,Jemal A. Cancer Statistics,2016 [J]. CA Cancer J Clin,2016,66:7-30.
  • 9Sethna KS, Sugarbaker PH. New prospects for the control of peritoneal surface dissemination of gastric cancer using perioperativeintraperitoneal chemotherapy[J].CancerTherapy, 2004,2 (A) : 79-84.
  • 10Kim MS,Choi C,Yoo S,et al. Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma [J]. Jpn J Clin Oncol, 2008,38(10):695-700.

引证文献14

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部